Novavax to Receive $350 Million for Cancelled COVID Vaccine Orders in Canada
According to a securities filing with the U.S. Securities and Exchange Commission (SEC) by Novavax Inc. of Gaithersburg, Maryland on June 30, 2023, the government of Canada will pay the company $349.6 million to settle the forfeiting of doses of its Nuvaxovid recombinant protein COVID-19 vaccine previously ordered and scheduled for delivery.1 2 Nuvaxvoid was […]
